Plasma Fractionation Market to Reach USD 38.65 Bn by 2026, Kedrion Biopharma’s FDA Approval to Create Attractive Growth Opportunities: Fortune Business Insights

    NEXT STORY
    Angion Presents Data on the Impact and Burden of Delayed Graft Function at the American Society of Nephrology Kidney Week 2019
    PREV STORY
    Ziopharm Oncology Presentation at the Jefferies 2019 London Healthcare Conference to be Webcast
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Novartis PREVENT data show Cosentyx® helps patients realize early and lasting relief in axial spondyloarthritis

    author_avatar
    NASDAQ Market News

    The European Medicines Agency accepts the regulatory submission for Lumoxiti in relapsed or refractory hairy cell leukemia

    author_avatar
    NASDAQ Market News

    FIT Biotech Oy: Conversion of FIT Biotech Oy’s Convertible Capital Notes into shares

    FIT Biotech Oy Company release March 14, 2018 at 03:30 PM EET Conversion of ...

    author_avatar
    NASDAQ Market News